PALLD palladin, cytoskeletal associated protein
Gene ID: 23022, updated on 27-Nov-2024Gene type: protein coding
Also known as: MYN; PNCA1; CGI151; SIH002; CGI-151
- See all available tests in GTR for this gene
- Go to complete Gene record for PALLD
- Go to Variation Viewer for PALLD variants
Summary
This gene encodes a cytoskeletal protein that is required for organizing the actin cytoskeleton. The protein is a component of actin-containing microfilaments, and it is involved in the control of cell shape, adhesion, and contraction. Polymorphisms in this gene are associated with a susceptibility to pancreatic cancer type 1, and also with a risk for myocardial infarction. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2009]
Associated conditions
See all available tests in GTR for this gene
Description | Tests |
---|---|
Genome-wide association study identifies variants associated with histologic features of nonalcoholic Fatty liver disease. GeneReviews: Not available | |
Pancreatic cancer, susceptibility to, 1 | See labs |
Whole genome association study identifies polymorphisms associated with QT prolongation during iloperidone treatment of schizophrenia. GeneReviews: Not available |
Genomic context
- Location:
- 4q32.3
- Sequence:
- Chromosome: 4; NC_000004.12 (168497052..168928441)
- Total number of exons:
- 28
Variation
Resource | Links for this gene |
---|---|
ClinVar | Variants reported to ClinVar |
dbVar | Studies and variants |
SNP | Variation Viewer for PALLD variants |
Genome viewer | Explore NCBI-annotated and select non-NCBI annotated genome assemblies |
- ClinVarRelated medical variations
- dbVarLink from Gene to dbVar
- MedGenRelated information in MedGen
- OMIMLink to related OMIM entry
- PALLD database
- PubMed (OMIM)Gene links to PubMed derived from omim_pubmed_cited links
- RefSeq RNAsLink to Nucleotide RefSeq RNAs
- RefSeqGeneLink to Nucleotide RefSeqGenes
- Variation ViewerRelated Variants
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.